Description

The global herg screening market is poised to grow by US$ 1,258.3 million during 2022-2028, progressing at a CAGR of 9.3% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for herg screening. The global herg screening market is segmented on the basis of type, ion channel, application, and region. By type, the global herg screening market has been segmented into gene KCNH2, mutant KCNH2. Based upon ion channel, the global herg screening market is categorized into ligand-gated ion channels, voltage-gated ion channels, others. On the basis of application, the global herg screening market has been segmented into antiarrhythmic, antibiotics, antipsychotics, others. Geographically, the global herg screening market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global herg screening market is highly competitive. The report also includes the profiles of leading companies such as Abcam PLC, Aurora Biomed Inc., B’SYS GmbH, Charles River Laboratories International Inc., Creative Bioarray, Eurofins Scientific SE, Merck KGaA, Metrion Biosciences Ltd., Thermo Fisher Scientific Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the herg screening market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Type: gene KCNH2, mutant KCNH2
Ion channel: ligand-gated ion channels, voltage-gated ion channels, others
Application: antiarrhythmic, antibiotics, antipsychotics, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global herg screening market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Herg screening market overview
Part 3. Market breakdown by type
– Gene KCNH2
– Mutant KCNH2
Part 4. Market breakdown by ion channel
– Ligand-gated ion channels
– Voltage-gated ion channels
– Others
Part 5. Market breakdown by application
– Antiarrhythmic
– Antibiotics
– Antipsychotics
– Others
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Abcam PLC
– Aurora Biomed Inc.
– B’SYS GmbH
– Charles River Laboratories International, Inc.
– Creative Bioarray
– Eurofins Scientific SE
– Merck KGaA
– Metrion Biosciences Ltd.
– Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer